03rd November 2021 | Pharma Updates
HC stops generic drug makers from making, selling patent drugs of Novartis
The high court’s order came on the plea by drug major Novartis, represented through advocate Mamta Jha, seeking to limit other drug makers from making or selling the patented combination of Sacubitril and Valsartan tablets.
Sun Pharma’s Growth Beats Estimates on Specialty Drug Push
Sun Pharma reported a 13% rise in net income to USD 274 mn.
Sun Pharma brings Winlevi in US market
Winlevi is the first USFDA approved acne drug with a first in class action mechanism in almost 40 yrs, Sun Pharma stated.
Guyana recognized Bharat Biotech's Covaxin
Indian High Commission in Guyana said it is an important step forward in the post pandemic partnership between both nations.
Civic Services buys Alps Pharma
Rajeev Malik Chief Legal Officer of Civic Services Holding Pvt. Ltd. said we are aiming to create sustainable and long term growth potential by becoming a leading drug maker in Uttarakhand.
India wants feedback on creating regulatory framework that aids innovation
India has proposed regulatory reforms intended to empower Research and Development and innovation in the drug and MedTech industries.
Remote care has changed the lives of heart patients
A device implanted under the human skin can detect the irregularities in heart rhythm.